Wall Street Junk Euphoria Backs Ackman’s Allergan Dreams
Wall Street Junk Euphoria Backs Ackman’s Allergan Dreams Bloomberg
View ArticleAs legislator rails on potential Valeant-Allergan deal, Wall Street lines up...
As legislator rails on potential Valeant-Allergan deal, Wall Street lines up to fund it Fierce Pharma
View Article[video] Allergan's Largest Shareholder Sells Most of Holdings
[video] Allergan's Largest Shareholder Sells Most of Holdings Marketwatch/WSJ Online
View ArticleValeant To Report Strong Second-Quarter Earnings And Revenues
Valeant To Report Strong Second-Quarter Earnings And Revenues Bidness Etc
View ArticleValeant Pharmaceuticals posts 12-fold rise in net profit
Valeant Pharmaceuticals posts 12-fold rise in net profit Yahoo/Reuters
View ArticleDoes Valeant’s Cost-Cutting Go Too Far?
Does Valeant’s Cost-Cutting Go Too Far? ProPublica
View ArticleValeant says on hunt for more deals, including contact lenses
Valeant says on hunt for more deals, including contact lenses Yahoo/Reuters
View ArticleAs Valeant’s Stock Drops, So Does Its Takeover Price for Allergan
As Valeant’s Stock Drops, So Does Its Takeover Price for Allergan WSJ Online
View ArticleAllergan Files Lawsuit in Federal Court against Valeant and Pershing Square...
Allergan Files Lawsuit in Federal Court against Valeant and Pershing Square for Violations of Federal Securities Laws Marketwatch
View Article3 Stocks Pushing The Drugs Industry Lower
3 Stocks Pushing The Drugs Industry Lower TheStreet.com
View ArticleDealpolitik: Allergan Throws Complex Road Block at Valeant, Pershing Square
Dealpolitik: Allergan Throws Complex Road Block at Valeant, Pershing Square WSJ Online
View ArticleAllergan Comments on Valeant’s Second Quarter 2014 Earnings Results
Allergan Comments on Valeant’s Second Quarter 2014 Earnings Results Yahoo
View ArticleAllergan Being ’Obstructive’ in Deal Defense, Firm Says
Allergan Being ’Obstructive’ in Deal Defense, Firm Says Bloomberg
View ArticleProxy adviser ISS backs call for Allergan holder meeting
Proxy adviser ISS backs call for Allergan holder meeting Marketwatch
View ArticleDealpolitik: Did Valeant Make a Strategic Error in Its Allergan Bid?
Dealpolitik: Did Valeant Make a Strategic Error in Its Allergan Bid? WSJ Online
View ArticleMost popular news headlines for Thursday, August 7 2014
The most-clicked news item for Thursday was “Pharma shares sink as U.S. threatens tax-inversion crackdown.” The US Treasury Department has announced that it is looking into undisclosed measures to...
View ArticleMost popular news headlines for Thursday, August 7 2014
Most popular news headlines for Thursday, August 7 2014 CP Wire
View ArticleNicox to co-promote eye drug with Bausch + Lomb in the US
Nicox to co-promote eye drug with Bausch + Lomb in the US Yahoo/Reuters
View ArticleCalifornia judge sets Aug. 20 hearing in Allergan vs Valeant case
California judge sets Aug. 20 hearing in Allergan vs Valeant case Yahoo/Reuters
View Article